Solid State Forms Of Selexipag

Patent No. EP3344607 (titled "Solid State Forms Of Selexipag") was filed by Teva Pharmaceuticals on Sep 2, 2016. The application was issued on Nov 6, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HGFAug 5, 2020HGF
CHIESI FARMACEUTICIFeb 6, 2020BIANCHETTI & MINOJA WITH TREVISAN & CUONZO IPS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3344607

TEVA PHARMACEUTICALS
Application Number
EP16766424A
Filing Date
Sep 2, 2016
Status
Revoked
Jul 19, 2024
Publication Date
Nov 6, 2019